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Abstract 
Background: Exercise can reduce osteoporotic fracture risk by strengthening bone or 
reducing fall risk. Falls prevention exercise programmes can reduce fall incidence, 
and also include strengthening exercises suggested to load bone, but there is little 
information as to whether these programmes influence bone mineral density (BMD) 
and strength.  
Objective: To evaluate the skeletal effects of home (Otago Exercise Programme, 
OEP) and group (Falls Exercise Management, FaME) falls prevention exercise 
programmes relative to usual care in older people. 
Methods: Men and women aged over 65 years were recruited through primary care. 
They were randomised by practice to OEP, FaME or usual care. Bone mineral 
density (BMD), bone mineral content (BMC) and structural properties were 
measured in Nottingham site participants before and after the 24 week intervention.  
Results: Participants were 319 men and women, aged mean(SD) 72(5) years. 92% 
of participants completed the trial. The OEP group completed 58(43) minutes/week 
of home exercise, whilst the FaME group completed 39(16) and 30(24) 
minutes/week of group and home exercise respectively. Femoral neck BMD changes 
did not differ between treatment arms: mean (95% CI) effect sizes in OEP and FaME 
relative to usual care arm were -0.003(-0.011,0.005) and -0.002(-0.010,0.005) g/cm2 
respectively; P=0.44 and 0.53.  There were no significant changes in BMD or BMC at 
other skeletal sites, or in structural parameters. 
Conclusions: Falls prevention exercise programmes did not influence BMD in older 
people. To increase bone strength, programmes may require exercise that exerts 
higher strains on bone or longer duration. 
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Key points 
This study examined whether strength and balance training programmes 
influence bone mineral density (BMD) in older people 
319 participants were randomised to 6 months of group exercise, home exercise 
or usual care 
The exercise interventions had no significant effect on BMD or bone structural 
parameters. 
To increase bone strength, exercise programmes may need to generate greater 
bone strains and/or have a longer duration. 
Introduction 
Osteoporosis is increasingly prevalent: in the UK it is estimated that over half of 
women, and a fifth of men aged 50, will sustain a fragility fracture (1). Physical 
activity may benefit bone mass, reducing the risk of osteoporotic fracture. The 
efficacy of exercise has received less attention relative to pharmaceutical treatments, 
although there is evidence that low load activities such as walking have at most a 
modest effect on bone mineral density (BMD) whilst high impact exercise or high 
intensity resistance training produce the greatest response (2, 3).  
The risk of fracture depends also upon the risk of falling. Strength and balance 
training programmes such as the Otago Exercise Programme (OEP) and Falls 
Management Exercise (FaME) are designed to reduce fall risk in older people. OEP 
is a home-based programme, reported to be effective in reducing the number of falls 
and fall-related injuries, improving strength and balance and was cost-effective for 
those aged over 80 years (4-8). FaME includes group exercise delivered by trained 
postural stability instructors and has been found to reduce the number of falls and 
injuries from falls (9, 10). Both interventions include resistance exercises designed to 
load bone, and high load resistance exercise can benefit BMD in older people (2, 11). 
Participation in FaME reduced bone loss at Ward’s triangle in postmenopausal 
women (12). Therefore these falls prevention interventions could be effective for 
improving bone strength as well as reducing fall risk. 
This study aimed to determine the effectiveness on BMD of community (FaME) and 
home based (OEP) exercise interventions compared to usual care in older people. 
Methods 
Experimental Design 
Participants were recruited from the ProAct65+ trial, a major primary care based trial 
comparing group exercise (FaME) and home based exercise (OEP) with usual care 
in older people (registered as ISRCTN43453770). This trial recruited participants 
through general practices at two sites: London and Nottingham, UK. Trial 
statisticians conducted randomisation by practice using minimisation for trial centre, 
practice size and the index of multiple deprivation (13).  At the baseline assessment 
(between 2009 and 2011), trial researchers invited all participants enrolled in the 
Nottingham site to participate in the bone sub-study. Volunteers attended additional 
visits at baseline and at the end of the intervention for measurements of BMD by 
bone study researchers. Bone study researchers conducting measurements and 
analysing data were not aware of participants’ intervention allocation, although 
participants were aware which intervention they were receiving. The study was 
approved by the National Research Ethics Service and University Ethics Advisory 
Committee. All participants provided written informed consent. 
Participants 
Participants were recruited through general practices located in Nottinghamshire and 
Derbyshire, UK (13). Inclusion criteria specified that participants were men and 
women aged 65 years or over, able to walk around at home and participate in an 
exercise programme. Patients were excluded if they had experienced three or more 
falls in the previous year, had unstable clinical conditions, would be unable to follow 
instructions about exercise safely, were receiving palliative care or were already 
exercising at or above the target level (13). We estimated that 142 participants per 
group would be required to detect a difference in response in dual hip BMD between 
intervention and usual care group of 0.005(0.014) gcm-2 with power of 80%, 5% 
significance level, assuming a two-sided comparison.  
Interventions 
The interventions were home based exercise (OEP) and community based exercise 
(FaME), which were compared with usual care. Interventions were delivered for 6 
months (24 weeks). The interventions have been described in more detail previously 
(13); key features are summarised below. 
The OEP programme consisted of three, 30-minute home exercise sessions and at 
least two 30-minute sessions of walking at a moderate pace each week. The home 
exercise sessions were introduced by trial research staff in a one-off training session, 
and consisted of progressive leg strengthening and balance exercises. Each 
participant received an instruction booklet and ankle cuff weights at the initial session, 
and was followed up by a peer mentor, where available, during a scheduled two 
home visits and eight telephone calls. The recruitment of peer mentors was difficult 
however, so the majority of participants did not have an assigned peer mentor(14). 
The FaME programme consisted of one 60-minute exercise class, two 30-minute 
home exercise sessions based on the OEP, and at least two 30-minute sessions of 
walking at a moderate pace each week. The exercise classes were delivered by a 
postural stability instructor and included progressive leg, arm and trunk muscle 
strengthening (using ankle cuff weights and Therabands); flexibility training; 
functional floor skills and adapted Tai Chi.  
Participants in the usual care group were not offered the FaME or OEP programmes, 
but were permitted to participate in physical activity as they would if they had not 
been participating in the trial. 
Outcome measures 
Outcome measures were assessed prior to randomisation, and at the end of the 
intervention/usual care period (at least 6 months from the start and within 4 weeks of 
the end of the intervention). The primary outcome measure was femoral neck BMD. 
Secondary outcomes were bone measurements at other skeletal sites. 
Dual X-ray absorptiometry (DXA) scans of the whole body, lumbar spine, proximal 
femur and distal forearm were conducted using  GE Lunar Prodigy Advance bone 
densitometers using Encore version 13.2 software. All scans for each participant 
were performed by the same operator on the same scanner. The short-term root-
mean-square coefficients of variation for femoral neck, upper neck, trochanter, total 
hip, lumbar spine, ultradistal radius and total body BMD were 1.3, 2.2, 1.2, 0.5, 1.2, 
4.3 and 0.7% respectively, whilst those for section modulus and strength index were 
3.6 and 7.7% and those for bone mass, fat mass and lean mass were 1.9, 1.9 and 
1.5%.  
During the baseline assessment at the participants’ general practice, interviews were 
conducted to determine participants’ age, ethnicity, socioeconomic status, health 
status and medication use (13). Subjective habitual physical activity assessment 
included the CHAMPS questionnaire (15). Dietary intake and supplement use (16), 
osteoporosis medication and age at menopause,  were assessed by questionnaire 
during the additional bone sub-study assessment at baseline and follow-up visits. 
All participants were requested to complete and return monthly diaries summarising 
their daily participation (in minutes) in FaME classes, home exercise sessions and 
walking.  
Statistical analysis: 
Data for those that agreed to participate in the ProAct65+ bone study were 
compared to those in the main ProAct65+ trial who did not volunteer to evaluate 
possible bias, using unpaired t, Mann-Whitney or chi-squared tests as appropriate. 
Descriptive statistics were calculated and compared descriptively between treatment 
arms. Data for participants who had commenced or ceased osteoporosis medication 
during the trial were excluded. Comparisons between treatment arms were made 
using random effects linear regression models to allow for clustering by practice, 
adjusted for baseline values, gender, antiresorptive medication use and 
comorbidities (major surgery in previous year, asthma, diabetes, thyroid or oral 
steroid medication use). Analysis was repeated with participants with illness or 
medication that may substantively affect bone excluded (i.e. osteoporosis medication, 
oral steroids, major surgery in previous 12 months), and in compliers only, i.e. 
participants in exercise arms that completed at least 75% of the prescribed 
group/home exercise. 
Economic analysis: 
The main ProAct65+ trial included an embedded economic analysis.  Within the 
bone health study, the intention was to conduct a cost-effectiveness analysis to 
compare each intervention with the usual care condition with respect to the primary 
outcome (femoral neck BMD). The resources involved in the delivery of each 
intervention were gathered from study records, and included instructors, facilities (for 
FaME classes) and equipment.  The full economic costs, from a health service 
perspective, were calculated in British pounds, 2011, using validated staff unit costs 
(17) and actual expenditures.   
Results 
Out of the 651 participants from 21 general practices in the Nottingham arm of the 
ProAct65+ study, 365 participants expressed an interest in the bone study. Of these, 
319 agreed to participate and attended for baseline measurements and 293 for 
follow-up measurements (Figure 1).  
Participants in the ProAct65+ trial who volunteered for the bone study were younger, 
had fewer co-morbidities, higher levels of education and higher household income 
and physical activity than those who did not volunteer (Supplementary Table). Height, 
weight and the proportion of female participants were not significantly different 
between bone study participants and non-participants. 
The characteristics of participants in each treatment arm are summarised in Table 1. 
The proportion of female participants was lowest in the usual care arm (54%) and 
highest in the OEP arm (68%). The proportion taking osteoporosis medication (all 
using anti-resorptive therapy) was higher in the FAME than in the usual care arm. 
Despite this, BMD and structural parameters were similar in the three treatment arms.  
OEP participants averaged 58(43) minutes of home exercise and 166(172) minutes 
of walking each week. FaME participants reported less home exercise and walking 
[30(24) and 133(101) minutes] but also attended 39(16) minutes of FaME class each 
week. The usual care group also reported 15(32) minutes of home exercise and 
121(121) minutes of walking per week. Adverse events were minimal and have been 
reported previously (18). 
Ten participants started or stopped taking osteoporosis medication during the trial 
and their data were excluded from further analysis. 
Femoral neck BMD (adjusted for baseline BMD, gender, major illness/surgery in last 
12 months and osteoporosis, oral steroid, asthma, diabetes and thyroid medication 
use) did not differ between treatment arms, with effect sizes in OEP and FaME 
relative to usual care arms being -0.003 and -0.002 g/cm2 (P=0.44 and 0.53) 
respectively, (-0.3% and -0.2% of the baseline value; Table 2; Supplementary 
Figure).  
Similarly there were no differences between treatment arms in BMD at other hip sites, 
lumbar spine or total body; or in structural parameters section modulus and femur 
strength index (Table 2). Distal radius BMD declined in the FaME arm relative to 
usual care, (-2.0% relative to baseline value, Table 2). Body fat mass also reduced 
by 0.65kg in FaME relative to the usual care arm, although there were no significant 
effects on lean mass.  
A sensitivity analysis was conducted excluding participants without major surgery in 
the past 12 months, osteoporosis medication and/or oral steroids (n= 65, 78 and 94 
in OEP, FaME and usual care respectively). Effect sizes were very similar and there 
were no significant effects. The decline in ultradistal radius BMD in the FaME group 
relative to usual care was smaller (effect size [95% confidence intervals] -0.006 [-
0.015, 0.003]) and no longer statistically significant (p=0.182). 
Analyses were repeated in 29 OEP and 27 FaME participants who had completed 
over 75% of the recommended duration of group and/or home exercise. There were 
again no significant effects on bone variables, with the effect size for femoral neck 
BMD in OEP relative to usual care being 0.000 [ -0.009, 0.009] g/cm2, p=0.98. 
Corresponding values in the FaME participants were 0.001 [-0.008, 0.010] g/cm2; 
p=0.86. 
The health service cost of the six-month FaME exercise programme delivered in the 
trial was approximately £218 (77% of which was for the group instructors).  The OEP 
programme cost approximately £36 per participant without a peer-mentor, which was 
mostly for the induction session and ankle cuffs (18). The corresponding cost for 
OEP participants with a peer mentor was £117.  In the absence of significant 
improvement in bone density arising from either exercise programme, compared to 
usual care, a cost-effectiveness analysis was not warranted. 
Discussion 
This study demonstrates that the six-month OEP and FaME exercise interventions 
did not benefit bone density in older people recruited through primary care.  
The lack of skeletal benefit in this study may result from the intervention not 
providing adequate skeletal loading. According to mechanostat theory, bone adapts 
when stresses applied to bone generate strains (minute deformations) that exceed 
those to which bone is habituated (19). Exercise that applies relatively high loading 
to bone can increase BMD even in older people (20). The magnitudes of loading 
resulting from OEP and FaME exercises may not have exceeded that to which 
participants were habituated.  
The duration of the intervention could also contribute to the lack of bone change in 
this study. The exercise interventions lasted only six months, which may have been 
inadequate to detect changes in mineralisation. Whilst bone gains from resistance 
training have been observed within as little as 16 weeks (21) greater benefit has 
been reported after 12 months (22). The FaME intervention that increased Ward’s 
triangle BMD (12) involved a 9 month intervention in a frailer group of women. 
Differences in the progression of interventions, i.e. the rate of increasing magnitude 
of weights lifted, may also explain differences between trials. In practice, however, 
falls prevention programmes are not delivered for more than 6 months (23) so this 
study reflects prevailing clinical practice. 
The unexpected reduction in BMD at the forearm in the FaME arm disappeared once 
participants with medical conditions or medications substantially affecting bone were 
excluded, so it seems likely that this apparent bone loss results from these factors, 
rather than the intervention. The FaME group also demonstrated a modest but 
statistically significant reduction in body fat content, which may confer further health 
benefits. Both findings however could be attributed to chance since their statistical 
significance was not strong, and a high number of variables were analysed. 
Bone strength depends also upon structural parameters, which may change with 
physical activity and age (24). Structural change may increase bone strength in the 
absence of any increase in BMD, so effects of exercise may be underestimated by 
using BMD alone (25). We measured section modulus, which is related to the bone’s 
strength in bending (26), and femur strength index, the estimated ratio of the 
strength of the bone relative to the stresses incurred in a fall (27). Neither parameter 
showed statistically significant effects. Areal BMD measured by DXA does not 
separate cortical and trabecular compartments. Distinguishing these may be 
important as exercise increased the amount of cortical bone (measured by 
quantitative computed tomography, QCT) without any change in areal BMD by DXA 
in one study (28). It is possible that QCT measures may have detected structural 
benefits not evident in this study. 
This study is one of the largest exercise intervention trials to have been conducted 
on bone health. Although we did not quite achieve our target sample size, we should 
have been able to detect modest BMD changes of less than 1%. The study benefits 
from a primary care setting and more representative sample of participants than 
most previous trials, which may make findings more broadly generalizable, although 
participants may still have been more active than the older population in general. 
Limitations include the limited duration of the intervention, although this reflects the 
likely scenario in clinical practice, where it may not be feasible to introduce 
interventions of greater duration. 
Whilst group or home based exercise programmes have an important role in 
reducing fracture risk by reducing risk of falls, they do not increase BMD. To benefit 
bone density and strength as well as reducing fall risk, interventions may require a 
greater magnitude of progressive loading, and/or a longer duration.  
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Figure 1: Flow of participants 
 
  
Participants in ProAct65+ main trial 
Nottingham site 
21 practices; 651 participants 
Randomised 
21 practices; 319 participants 
Excluded 
Refused to participate: 
332 participants 
Allocated to intervention FaME 
7 practices; 105 participants 
Allocated to intervention OEP 
6 practices; 88 participants 
Allocated to usual care 
8 practices; 126 participants 
Lost to follow-up:  
8 participants 
Lost to follow-up:  
11 participants 
Lost to follow-up:  
7 participants 
Analysed (90%) 
(7 practices; 94 participants) 
Excluded from analysis: started/ 
stopped osteoporosis medication  
(3 participants) 
Analysed (85%) 
(6 practices; 75 participants) 
Excluded from analysis: started/ 
stopped osteoporosis medication  
(2 participants) 
Analysed (90%) 
(8 practices; 114 participants) 
Excluded from analysis: started/ 
stopped osteoporosis medication 
(5 participants) 
Analysis 
Follow-up 
Allocation 
Enrollment 
Table 1: Baseline characteristics of bone study participants according to 
treatment arm: mean (SD) or number (%) 
 OEP  
(n=88) 
FAME  
(n=105) 
Usual care 
(n=126) 
Age (y) 71.4 (4.9) 71.8 (5.5) 72.2 (5.5) 
Height (cm) 163.8 (9.6) 164.8 (9.3) 165.3 (8.7) 
Weight (kg) 71.8 (5.5) 76.7 (14.4) 78.2 (16.6) 
%fat 38.5 (8.8) 36.6 (8.2) 36.6 (8.9) 
Female 60 (68.2%) 63 (60.0%) 68 (54.0%) 
Ethnicity 
   Asian 
   Other 
   White 
   Not specified 
 
1 (1.1%) 
0 (0.0%) 
87 (98.9%) 
0 (0.0%) 
 
2 (1.9%) 
0 (0.0%) 
102 (97.1%) 
1 (1.0%) 
 
3 (2.4%) 
3 (2.4%) 
119 (94.4%) 
1 (0.8%) 
Osteoporosis medication 5 (5.7%) 11 (10.5%) 3 (2.4%) 
Diabetes medication 7 (8.0%) 10 (9.5%) 13 (10.4%) 
Thyroid medication 8 (9.1%) 6 (5.7%) 9 (7.2%) 
Oral steroids 1 (1.1%) 4 (3.8%) 4 (3.2%) 
Asthma medication 3 (3.4%) 9 (8.6%) 15 (12.0%) 
Oestrogen replacement 2 (2.3%) 0 (0.0%) 2 (1.6%) 
Major surgery/illness 4 (4.5%) 7 (6.7%) 2 (1.6%) 
Total body BMD (gcm-2) 1.113 (0.119) 1.123 (0.123) 1.133 (0.134) 
Lumbar spine (L2-4) BMD (g cm-2) 1.147 (0.206) 1.161 (0.215) 1.176 (0.234) 
Ultradistal radius BMD (g cm-2) 0.431 (0.100) 0.448 (0.112) 0.446 (0.101) 
Femoral neck BMD (g cm-2) 0.897 (0.128) 0.889 (0.143) 0.910 (0.150) 
Trochanter BMD (g cm-2) 0.789 (0.156) 0.794 (0.166) 0.814 (0.182) 
Total hip BMD (g cm-2) 0.946 (0.148) 0.939 (0.160) 0.959 (0.175) 
Upper neck BMD (g cm-2) 0.720 (0.133) 0.723 (0.141) 0.736 (0.146) 
Femur strength index 1.37 (0.35) 1.35 (0.27) 1.46 (0.37) 
Section modulus (mm3) 615 (191) 644 (198) 670 (212) 
Started/stopped osteoporosis 
treatment during trial 
2 (2.5%) 3 (3.1%) 5 (4.1%) 
 
  
Table 2: Random effects linear regression summarising effect size in FaME 
and OEP relative to usual care: differences between means, 95% confidence 
intervals and p values. 
 OEP FaME 
Femoral neck BMD (g/cm2) -0.003 (-0.011, 0.005) 
P=0.442 
-0.002 (-0.010, 0.005) 
P=0.526 
Trochanter BMD (g/cm2) -0.005 (-0.032, 0.022) 
P=0.701 
0.000 (-0.025, 0.026) 
P=0.980 
Total hip BMD (g/cm2) -0.008 (-0.034, 0.019) 
P=0.362 
0.003 (-0.022, 0.028) 
P=0.955 
Upper neck BMD (g/cm2) 0.003 (-0.018, 0.023) 
P=0.785 
0.006 (-0.013, 0.026) 
P=0.516 
Section modulus (mm3) -8.5 (-21.7, 4.7) 
p=0.205 
-6.9 (-19.3, 5.6) 
p=0.277 
Femur strength index 0.008 (-0.035, 0.052)  
p=0.704 
0.036 (-0.005, 0.078) 
P=0.084 
Lumbar spine (L2-4) BMD (g/cm2) 0.003 (-0.012, 0.019) 
P=0.649 
0.005 (-0.010, 0.020) 
P=0.497 
Distal radius BMD (g/cm2) 0.001 (-0.008, 0.010) 
P=0.857 
-0.009 (-0.018, -0.000) 
P=0.042 
Total body BMD  (g/cm2) 0.003 (-0.002, 0.008) 
P=0.257 
-0.003 (-0.007, 0.002) 
P=0.206 
Total body bone mineral content (g) 0.8 (-22.0, 23.6) 
P=0.945 
-6.6 (-27.9, 14.7) 
P=0.542 
Fat mass (kg)  0.31 (-0.24, 0.87) 
P=0.271 
-0.57 (-1.09, 0.05) 
P=0.033 
Lean mass (kg) -0.17 (-0.62, 0.28) 
P=0.446 
-0.08 (-0.51, 0.36) 
P=0.718 
Adjusted for baseline value, gender, major illness/surgery in last 12 months, 
osteoporosis medication, oral steroids, asthma medication, diabetes medication, 
thyroid medication 
 
  
Supplementary Table: Comparison of characteristics of ProAct65+ bone study 
participants with non-participants from Nottingham site of the main ProAct65+ 
trial 
 Non-participants in 
bone study 
(N=332) 
Participants in 
bone study 
(N=319) 
p-
value 
Female a 
 
216 (65.1%) 193 (60.5%) 0.256  
Ethnicity a 
White 
Asian 
Black Caribbean 
Other 
Missing 
 
306 (92.1%) 
4 (1.2%) 
10 (3.0%) 
7 (2.1%) 
5 (1.5%) 
 
291 (91.2%) 
6 (1.9%) 
2 (0.6%) 
13 (4.1%) 
7 (2.2%) 
 
0.093 
Highest level of education a 
Primary 
Secondary 15/16 
Secondary 17/18 
Further education 
University 
Missing 
 
23 (6.9%) 
180 (54.2%) 
20 (6.0%) 
67 (20.2%) 
33 (9.9%) 
9 (2.7%) 
 
3 (0.9%) 
162 (50.8%) 
20 (6.3%) 
84 (26.3%) 
44 (13.8%) 
6 (1.9%) 
 
 
0.001 
Household income before 
tax a 
< 12000 
12001-20000 
20001-30000 
30001-45000 
45001+ 
missing 
 
108 (32.5%) 
80 (24.1%) 
37 (11.1%) 
20 (6.0%) 
3(0.9%) 
84 (25.3%) 
 
89 (27.9%) 
88 (27.6%) 
67 (21.0%) 
24 (7.5%) 
12 (3.8%) 
39 (12.2%) 
 
 
 
<0.001 
Smoking a 
Current 
Ex 
Never 
 
22 (6.6%) 
162 (48.9%) 
147 (44.4%) 
 
15 (4.7%) 
146 (45.8%) 
158 (49.5%) 
 
0.312 
Age (y) b 
 
73.9 (6.3) 71.9 (5.3) <0.001 
Height (m) b 
 
1.66 (0.09) 1.67 (0.10) 0.115 
Weight (kg) b 
 
74.6 (16.2) 76.2 (15.5) 0.226 
BMI (kg m-2) b 
 
27.1 (4.9) 27.3 (5.1) 0.511 
Number comorbidities b 
 
2.54 (1.68) 2.26 (1.59) 0.033 
Energy expenditure all 
activities cd 
1508.8 (1944.2) 1831.9 (2104.3) 0.003 
Energy expenditure 
moderate activities cd 
358.8 (1045.1) 671.8 (1408.4) <0.001 
a number (%), Chi-squared test; b mean (SD), independent samples T; c median 
(IQR), Mann-Whitney U; d estimated from CHAMPS questionnaire responses. 
  
  
 
Supplementary Figure: BMD changes in OEP, FaME and usual care arms: 
Mean (95% confidence intervals). Adjusted for baseline value, gender, major 
illness in last 12 months, osteoporosis medication use, oral steroids, asthma 
medication, diabetes medication, thyroid medication. 
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